Catalio Capital Management
Overview
Catalio Capital Management is a multi-strategy life sciences investment firm that focuses on breakthrough biomedical technology companies developing the next generation of drugs, devices, diagnostics, and data-driven insights. The firm invests in various asset classes like private equity, private credit and public equity and employs a long bias, fundamental, bottoms-up equity and long/short strategy to invest.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Lila Sciences | Oct 2025 | Series A Extension | Co-investor |
| Neumora | Oct 2021 | Series A | Co-investor |
| Flourish Inc. | Jun 2026 | VC Round | Co-investor |
| Parabilis Medicines | Jan 2026 | Series F | Co-investor |
| Fog Pharmaceuticals | Jan 2026 | Series F | Co-investor |
For institutional investors. Book with your work email.
Key People
George Petrocheilos
Co-Founder & Managing Partner
R. Jacob Vogelstein
Co-Founder And Managing Partner
John Henry Iucker
General Partner Head Of Credit
Ajay Mantha
Partner
Ben Snedeker
Partner & Head of Public Equities
Charlie Nettleton
Partner, Co-Head Public Equities
Isaac Ro
Partner
Jonathan Blankfein
Partner, Portfolio Manager
Olga Maltseva
Partner Head Of Operations
Tom Brooks
Partner
Matthew J. Hobson
Principal
Scott O'Sullivan
Principal, Head Trader
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Catalio Capital Management based?
Catalio Capital Management is headquartered in New York City, New York, United States.
When was Catalio Capital Management founded?
Catalio Capital Management was founded in 2020.
How many portfolio companies does Catalio Capital Management have?
Catalio Capital Management has 85 portfolio companies in Caplight's dataset.
What are some companies in Catalio Capital Management's portfolio?
Portfolio companies visible on Caplight include Lila Sciences, Neumora, Flourish Inc., Parabilis Medicines, Fog Pharmaceuticals.
What was Catalio Capital Management's most recent investment shown here?
Catalio Capital Management's most recent investment in this portfolio sample was in Flourish Inc. in 2026.
What sectors does Catalio Capital Management focus on?
Catalio Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Consumer & Commerce, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software.
What company stages does Catalio Capital Management focus on?
Catalio Capital Management typically invests at the MultiStage stage.
What is Catalio Capital Management's AUM?
Catalio Capital Management's assets under management are estimated between $1.0B and $10.0B.